Q-omics provides the consensus-scored USP17L23 profile across patient tissues and cancer cell-line models.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for USP17L23 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

Locus: 4p16.1 &middot; ubiquitin specific peptidase 17 like family member 23
External: <a href="https://www.ncbi.nlm.nih.gov/gene/101241878" target="_blank" rel="noopener" class="lin">NCBI Gene

This table shows molecular features associated with USP17L23 in patient tissues and cancer cell lines. In cancer cell lines, USP17L23 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BREAST.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	83	BREAST (58)	view →
Mutation	13	BREAST (10)	view →